ESCRS - Pictorial highlights from AAO 2016, Chicago ;

Pictorial highlights from AAO 2016, Chicago

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Ensuring access to advanced cell therapies amid regulatory overhaul.

Winter Meeting offers opportunities to experiment with new concepts and formats.

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Patient education key to satisfaction with refractive IOLs.

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Weighing the pros and cons of options for intraocular intervention.

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

;